ArticleCancer medicine2025

Characterisation of HER2-Driven Morphometric Signature in Breast Cancer and Prediction of Risk of Recurrence.

N M Atallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.